503 related articles for article (PubMed ID: 21622980)
1. Early drop in systolic blood pressure and worsening renal function in acute heart failure: renal results of Pre-RELAX-AHF.
Voors AA; Davison BA; Felker GM; Ponikowski P; Unemori E; Cotter G; Teerlink JR; Greenberg BH; Filippatos G; Teichman SL; Metra M;
Eur J Heart Fail; 2011 Sep; 13(9):961-7. PubMed ID: 21622980
[TBL] [Abstract][Full Text] [Related]
2. Design of the RELAXin in acute heart failure study.
Ponikowski P; Metra M; Teerlink JR; Unemori E; Felker GM; Voors AA; Filippatos G; Greenberg B; Teichman SL; Severin T; Mueller-Velten G; Cotter G; Davison BA
Am Heart J; 2012 Feb; 163(2):149-55.e1. PubMed ID: 22305830
[TBL] [Abstract][Full Text] [Related]
3. Association of Early Blood Pressure Decrease and Renal Function With Prognosis in Acute Heart Failure.
Matsue Y; Sama IE; Postmus D; Metra M; Greenberg BH; Cotter G; Davison BA; Felker GM; Filippatos G; Pang P; Ponikowski P; Severin T; Gimpelewicz C; Voors AA; Teerlink JR
JACC Heart Fail; 2021 Dec; 9(12):890-903. PubMed ID: 34627724
[TBL] [Abstract][Full Text] [Related]
4. Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes.
Metra M; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Ponikowski P; Unemori E; Voors AA; Adams KF; Dorobantu MI; Grinfeld L; Jondeau G; Marmor A; Masip J; Pang PS; Werdan K; Prescott MF; Edwards C; Teichman SL; Trapani A; Bush CA; Saini R; Schumacher C; Severin T; Teerlink JR;
J Am Coll Cardiol; 2013 Jan; 61(2):196-206. PubMed ID: 23273292
[TBL] [Abstract][Full Text] [Related]
5. Early drop in systolic blood pressure, heart rate at admission, and their effects on worsening renal function in elderly patients with acute heart failure.
Takeuchi M; Nagai M; Dote K; Kato M; Oda N; Kunita E; Kagawa E; Yamane A; Kobayashi Y; Shiota H; Osawa A; Kobatake H
BMC Cardiovasc Disord; 2020 Aug; 20(1):366. PubMed ID: 32778073
[TBL] [Abstract][Full Text] [Related]
6. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.
Teerlink JR; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Ponikowski P; Unemori E; Voors AA; Adams KF; Dorobantu MI; Grinfeld LR; Jondeau G; Marmor A; Masip J; Pang PS; Werdan K; Teichman SL; Trapani A; Bush CA; Saini R; Schumacher C; Severin TM; Metra M;
Lancet; 2013 Jan; 381(9860):29-39. PubMed ID: 23141816
[TBL] [Abstract][Full Text] [Related]
7. Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study.
Teerlink JR; Metra M; Felker GM; Ponikowski P; Voors AA; Weatherley BD; Marmor A; Katz A; Grzybowski J; Unemori E; Teichman SL; Cotter G
Lancet; 2009 Apr; 373(9673):1429-39. PubMed ID: 19329178
[TBL] [Abstract][Full Text] [Related]
8. Transient worsening of renal function during hospitalization for acute heart failure alters outcome.
Logeart D; Tabet JY; Hittinger L; Thabut G; Jourdain P; Maison P; Tartiere JM; Solal AC
Int J Cardiol; 2008 Jul; 127(2):228-32. PubMed ID: 17651843
[TBL] [Abstract][Full Text] [Related]
9. Representativeness of RELAX-AHF clinical trial population in acute heart failure.
Wang TS; Hellkamp AS; Patel CB; Ezekowitz JA; Fonarow GC; Hernandez AF
Circ Cardiovasc Qual Outcomes; 2014 Mar; 7(2):259-68. PubMed ID: 24594552
[TBL] [Abstract][Full Text] [Related]
10. Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study.
Teerlink JR; Voors AA; Ponikowski P; Pang PS; Greenberg BH; Filippatos G; Felker GM; Davison BA; Cotter G; Gimpelewicz C; Boer-Martins L; Wernsing M; Hua TA; Severin T; Metra M
Eur J Heart Fail; 2017 Jun; 19(6):800-809. PubMed ID: 28452195
[TBL] [Abstract][Full Text] [Related]
11. Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial.
Giamouzis G; Butler J; Starling RC; Karayannis G; Nastas J; Parisis C; Rovithis D; Economou D; Savvatis K; Kirlidis T; Tsaknakis T; Skoularigis J; Westermann D; Tschöpe C; Triposkiadis F
J Card Fail; 2010 Dec; 16(12):922-30. PubMed ID: 21111980
[TBL] [Abstract][Full Text] [Related]
12. Effect of nesiritide on renal function in patients admitted for decompensated heart failure.
Arora S; Clarke K; Srinivasan V; Gradman A
QJM; 2007 Nov; 100(11):699-706. PubMed ID: 17971392
[TBL] [Abstract][Full Text] [Related]
13. Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function.
Metra M; Davison B; Bettari L; Sun H; Edwards C; Lazzarini V; Piovanelli B; Carubelli V; Bugatti S; Lombardi C; Cotter G; Dei Cas L
Circ Heart Fail; 2012 Jan; 5(1):54-62. PubMed ID: 22167320
[TBL] [Abstract][Full Text] [Related]
14. Worsening renal function in children hospitalized with decompensated heart failure: evidence for a pediatric cardiorenal syndrome?
Price JF; Mott AR; Dickerson HA; Jefferies JL; Nelson DP; Chang AC; O'Brian Smith E; Towbin JA; Dreyer WJ; Denfield SW; Goldstein SL
Pediatr Crit Care Med; 2008 May; 9(3):279-84. PubMed ID: 18446113
[TBL] [Abstract][Full Text] [Related]
15. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients.
Butler J; Forman DE; Abraham WT; Gottlieb SS; Loh E; Massie BM; O'Connor CM; Rich MW; Stevenson LW; Wang Y; Young JB; Krumholz HM
Am Heart J; 2004 Feb; 147(2):331-8. PubMed ID: 14760333
[TBL] [Abstract][Full Text] [Related]
16. The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment.
Cotter G; Dittrich HC; Weatherley BD; Bloomfield DM; O'Connor CM; Metra M; Massie BM;
J Card Fail; 2008 Oct; 14(8):631-40. PubMed ID: 18926433
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of oral tolvaptan in acute heart failure patients with hypotension and renal impairment.
Vaduganathan M; Gheorghiade M; Pang PS; Konstam MA; Zannad F; Swedberg K; Grinfeld L; Burnett JC; Krasa HB; Zimmer C; Blair J; Ouyang J; Maggioni AP;
J Cardiovasc Med (Hagerstown); 2012 Jul; 13(7):415-22. PubMed ID: 22673023
[TBL] [Abstract][Full Text] [Related]
18. Early worsening heart failure in patients admitted for acute heart failure: time course, hemodynamic predictors, and outcome.
Torre-Amione G; Milo-Cotter O; Kaluski E; Perchenet L; Kobrin I; Frey A; Rund MM; Weatherley BD; Cotter G
J Card Fail; 2009 Oct; 15(8):639-44. PubMed ID: 19786251
[TBL] [Abstract][Full Text] [Related]
19. [The determination of the factors impacting on in-hospital mortality in patients with acute heart failure in a tertiary referral center].
Zoghi M; Duygu H; Güngör H; Nalbantgil S; Yilmaz GM; Tülüce K; Ozerkan F; Akilli A; Akin M
Anadolu Kardiyol Derg; 2008 Aug; 8(4):255-9. PubMed ID: 18676300
[TBL] [Abstract][Full Text] [Related]
20. Cardiorenal interactions: insights from the ESCAPE trial.
Nohria A; Hasselblad V; Stebbins A; Pauly DF; Fonarow GC; Shah M; Yancy CW; Califf RM; Stevenson LW; Hill JA
J Am Coll Cardiol; 2008 Apr; 51(13):1268-74. PubMed ID: 18371557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
